These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 16181465)
1. A randomized trial of topical 5% 5-fluorouracil (Efudix cream) in the treatment of actinic keratoses comparing daily with weekly treatment. Jury CS; Ramraka-Jones VS; Gudi V; Herd RM Br J Dermatol; 2005 Oct; 153(4):808-10. PubMed ID: 16181465 [TBL] [Abstract][Full Text] [Related]
2. Effect of a 1-week treatment with 0.5% topical fluorouracil on occurrence of actinic keratosis after cryosurgery: a randomized, vehicle-controlled clinical trial. Jorizzo J; Weiss J; Furst K; VandePol C; Levy SF Arch Dermatol; 2004 Jul; 140(7):813-6. PubMed ID: 15262691 [TBL] [Abstract][Full Text] [Related]
3. 5-fluorouracil 0.5% cream for multiple actinic or solar keratoses of the face and anterior scalp. Gupta AK; Weiss JS; Jorizzo JL Skin Therapy Lett; 2001 Jun; 6(9):1-4. PubMed ID: 11550079 [TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up. Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB; Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399 [TBL] [Abstract][Full Text] [Related]
5. Bilateral comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% 5-fluorouracil cream in the treatment of actinic keratoses of the face and scalp. Smith SR; Morhenn VB; Piacquadio DJ J Drugs Dermatol; 2006 Feb; 5(2):156-9. PubMed ID: 16485883 [TBL] [Abstract][Full Text] [Related]
6. Low-dose 5-fluorouracil in combination with salicylic acid as a new lesion-directed option to treat topically actinic keratoses: histological and clinical study results. Stockfleth E; Kerl H; Zwingers T; Willers C Br J Dermatol; 2011 Nov; 165(5):1101-8. PubMed ID: 21517801 [TBL] [Abstract][Full Text] [Related]
7. Comparison of 5% 5-fluorouracil cream and 5% imiquimod cream in the management of actinic keratoses on the face and scalp. Tanghetti E; Werschler P J Drugs Dermatol; 2007 Feb; 6(2):144-7. PubMed ID: 17373172 [TBL] [Abstract][Full Text] [Related]
8. One-week treatment with 0.5% fluorouracil cream prior to cryosurgery in patients with actinic keratoses: a double-blind, vehicle-controlled, long-term study. Jorizzo J; Weiss J; Vamvakias G J Drugs Dermatol; 2006 Feb; 5(2):133-9. PubMed ID: 16485881 [TBL] [Abstract][Full Text] [Related]
9. Randomized, double-blind, placebo-controlled prospective study of the efficacy of topical anaesthesia with a eutetic mixture of lignocaine 2.5% and prilocaine 2.5% for topical 5-aminolaevulinic acid-photodynamic therapy for extensive scalp actinic keratoses. Langan SM; Collins P Br J Dermatol; 2006 Jan; 154(1):146-9. PubMed ID: 16403108 [TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials. Piacquadio DJ; Chen DM; Farber HF; Fowler JF; Glazer SD; Goodman JJ; Hruza LL; Jeffes EW; Ling MR; Phillips TJ; Rallis TM; Scher RK; Taylor CR; Weinstein GD Arch Dermatol; 2004 Jan; 140(1):41-6. PubMed ID: 14732659 [TBL] [Abstract][Full Text] [Related]
11. A prospective randomized exploratory study comparing the efficacy of once-daily topical 0.5% 5-fluorouracil in combination with 10.0% salicylic acid (5-FU/SA) vs. cryosurgery for the treatment of hyperkeratotic actinic keratosis. Simon JC; Dominicus R; Karl L; Rodríguez R; Willers C; Dirschka T J Eur Acad Dermatol Venereol; 2015 May; 29(5):881-9. PubMed ID: 25257941 [TBL] [Abstract][Full Text] [Related]
12. A comparison of the efficacy and safety of Jessner's solution and 35% trichloroacetic acid vs 5% fluorouracil in the treatment of widespread facial actinic keratoses. Lawrence N; Cox SE; Cockerell CJ; Freeman RG; Cruz PD Arch Dermatol; 1995 Feb; 131(2):176-81. PubMed ID: 7857114 [TBL] [Abstract][Full Text] [Related]
13. Comparison of topical 5-fluorouracil formulations in actinic keratosis treatment. Kaur RR; Alikhan A; Maibach HI J Dermatolog Treat; 2010 Sep; 21(5):267-71. PubMed ID: 19878034 [TBL] [Abstract][Full Text] [Related]
14. Twice daily vs. four times daily 5-fluorouracil therapy for actinic keratoses: a split face study. Epstein E Br J Dermatol; 2006 Apr; 154(4):794-5. PubMed ID: 16536841 [No Abstract] [Full Text] [Related]
15. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis. Moloney FJ; Collins P Br J Dermatol; 2007 Jul; 157(1):87-91. PubMed ID: 17501954 [TBL] [Abstract][Full Text] [Related]
16. A clinical comparison and long-term follow-up of topical 5-fluorouracil versus laser resurfacing in the treatment of widespread actinic keratoses. Ostertag JU; Quaedvlieg PJ; van der Geer S; Nelemans P; Christianen ME; Neumann MH; Krekels GA Lasers Surg Med; 2006 Sep; 38(8):731-9. PubMed ID: 16912977 [TBL] [Abstract][Full Text] [Related]
17. Intermittent topical 5-fluorouracil is effective without significant irritation in the treatment of actinic keratoses but prolongs treatment duration. Labandeira J; Pereiro M; Valdés F; Toribio J Dermatol Surg; 2004 Apr; 30(4 Pt 1):517-20. PubMed ID: 15056141 [TBL] [Abstract][Full Text] [Related]
18. Facial resurfacing for nonmelanoma skin cancer prophylaxis. Hantash BM; Stewart DB; Cooper ZA; Rehmus WE; Koch RJ; Swetter SM Arch Dermatol; 2006 Aug; 142(8):976-82. PubMed ID: 16924046 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety assessment of 0.5% and 1% colchicine cream in the treatment of actinic keratoses. Akar A; Bülent Taştan H; Erbil H; Arca E; Kurumlu Z; Gür AR J Dermatolog Treat; 2001 Dec; 12(4):199-203. PubMed ID: 12241628 [TBL] [Abstract][Full Text] [Related]
20. Can topical calcipotriol be a treatment alternative in actinic keratoses? A preliminary report. Seckin D; Cerman AA; Yildiz A; Ergun T J Drugs Dermatol; 2009 May; 8(5):451-4. PubMed ID: 19537367 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]